Your browser doesn't support javascript.
loading
Copy number evolution and its relationship with patient outcome-an analysis of 178 matched presentation-relapse tumor pairs from the Myeloma XI trial.
Croft, James; Ellis, Sidra; Sherborne, Amy L; Sharp, Kim; Price, Amy; Jenner, Matthew W; Drayson, Mark T; Owen, Roger G; Chown, Sally; Lindsay, Jindriska; Karunanithi, Kamaraj; Hunter, Hannah; Gregory, Walter M; Davies, Faith E; Morgan, Gareth J; Cook, Gordon; Atanesyan, Lilit; Savola, Suvi; Cairns, David A; Jackson, Graham; Houlston, Richard S; Kaiser, Martin F.
Affiliation
  • Croft J; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
  • Ellis S; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
  • Sherborne AL; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
  • Sharp K; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
  • Price A; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
  • Jenner MW; Department of Haematology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Drayson MT; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Owen RG; Haematological Malignancy Diagnostic Service, St. James's University Hospital, Leeds, UK.
  • Chown S; Gloucestershire Hospitals NHS Foundation Trust, Gloucester, UK.
  • Lindsay J; Kent and Canterbury Hospital, Canterbury, UK.
  • Karunanithi K; University Hospital of North Midlands, Stoke-on-Trent, UK.
  • Hunter H; Derriford Hospital, Plymouth, UK.
  • Gregory WM; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, Leeds, UK.
  • Davies FE; Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA.
  • Morgan GJ; Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA.
  • Cook G; Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK.
  • Atanesyan L; MRC-Holland, Amsterdam, The Netherlands.
  • Savola S; MRC-Holland, Amsterdam, The Netherlands.
  • Cairns DA; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, Leeds, UK.
  • Jackson G; Department of Haematology, University of Newcastle, Newcastle Upon Tyne, UK.
  • Houlston RS; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
  • Kaiser MF; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Leukemia ; 35(7): 2043-2053, 2021 07.
Article in En | MEDLINE | ID: mdl-33262523
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: DNA Copy Number Variations / Multiple Myeloma Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: DNA Copy Number Variations / Multiple Myeloma Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Country of publication: